English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Work by T.J., P.P. and D.M.B. was awarded by Prostate Cancer Canada (PCC) and is proudly funded by the Movember Foundation-Grant #T2014-01. T.J. was supported by a Transformative Pathology Fellowship funded by the Ontario Institute for Cancer Research (OICR) through funding provided by the Government of Ontario. P.P was supported by Terry Fox Transdisciplinary Fellowship. V.O., A.-M.M.-M and F.S. are researchers of the Centre de recherche du Centre hospitalier de l'Universitéde Montréal which receives support from the FRQS. Biobanking was done in collaboration with the Réseau de Recherche sur le cancer of the Fonds de Recherche Québec - Santé (FRQS) that is affiliated with the Canadian Tumor Repository Network (CTRNet). TMA construction was supported by the Terry Fox Research Institute. F. Saad holds the Montreal University Research Chair in Prostate Cancer. J.A.S. and T.V. are supported by FAPESP grant no. 2015/09111-5. J.S. by CNPq Bolsa Produtividade em Pesquisa - Nàvel: PQ-1B grant no. 306864/2014-2. M.K. is supported by funding from Prostate Cancer Cancer, Terry Fox Research Institute-Canadian Prostate Cancer Biomarker Network and Canadian Institutes for Health Research.

MP28-02 QUANTITATIVE MEASUREMENT OF PTEN LOSS IMPROVES RISK ASSESSMENT IN PROSTATE CANCER